Hudock Inc’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-50
| Closed | – | – | 848 |
|
|
2022
Q2 | $0 | Hold |
50
| – | – | ﹤0.01% | 830 |
|
|
2022
Q1 | $0 | Hold |
50
| – | – | ﹤0.01% | 829 |
|
|
2021
Q4 | $0 | Hold |
50
| – | – | ﹤0.01% | 905 |
|
|
2021
Q3 | $0 | Hold |
50
| – | – | ﹤0.01% | 908 |
|
|
2021
Q2 | $0 | Hold |
50
| – | – | ﹤0.01% | 883 |
|
|
2021
Q1 | $1K | Hold |
50
| – | – | ﹤0.01% | 793 |
|
|
2020
Q4 | $1K | Hold |
50
| – | – | ﹤0.01% | 740 |
|
|
2020
Q3 | $2K | Hold |
50
| – | – | ﹤0.01% | 683 |
|
|
2020
Q2 | $2K | Hold |
50
| – | – | ﹤0.01% | 662 |
|
|
2020
Q1 | $3K | Hold |
50
| – | – | ﹤0.01% | 537 |
|
|
2019
Q4 | $5K | Hold |
50
| – | – | ﹤0.01% | 508 |
|
|
2019
Q3 | $3K | Hold |
50
| – | – | ﹤0.01% | 582 |
|
|
2019
Q2 | $3K | Hold |
50
| – | – | ﹤0.01% | 579 |
|
|
2019
Q1 | $5K | Hold |
50
| – | – | ﹤0.01% | 500 |
|
|
2018
Q4 | $4K | Hold |
50
| – | – | ﹤0.01% | 508 |
|
|
2018
Q3 | $6K | Hold |
50
| – | – | ﹤0.01% | 502 |
|
|
2018
Q2 | $4K | Hold |
50
| – | – | ﹤0.01% | 534 |
|
|
2018
Q1 | $3K | Hold |
50
| – | – | ﹤0.01% | 572 |
|
|
2017
Q4 | $2K | Hold |
50
| – | – | ﹤0.01% | 590 |
|
|
2017
Q3 | $2K | Hold |
50
| – | – | ﹤0.01% | 590 |
|
|
2017
Q2 | $6K | Hold |
50
| – | – | ﹤0.01% | 445 |
|
|
2017
Q1 | $5K | Hold |
50
| – | – | ﹤0.01% | 454 |
|
|
2016
Q4 | $5K | Hold |
50
| – | – | ﹤0.01% | 447 |
|
|
2016
Q3 | $8K | Hold |
50
| – | – | ﹤0.01% | 422 |
|
|
2016
Q2 | $7K | Hold |
50
| – | – | ﹤0.01% | 442 |
|
|
2016
Q1 | $6K | Hold |
50
| – | – | ﹤0.01% | 457 |
|
|
2015
Q4 | $7K | Hold |
50
| – | – | ﹤0.01% | 416 |
|
|
2015
Q3 | $8K | Hold |
50
| – | – | ﹤0.01% | 431 |
|
|
2015
Q2 | $12K | Hold |
50
| – | – | 0.01% | 383 |
|
|
2015
Q1 | $14K | Sell |
50
-75
| -60% | -$21K | 0.01% | 383 |
|
|
2014
Q4 | $20K | Hold |
125
| – | – | 0.01% | 318 |
|
|
2014
Q3 | $30K | Sell |
125
-175
| -58% | -$42K | 0.02% | 273 |
|
|
2014
Q2 | $71K | Buy |
+300
| New | +$71K | 0.08% | 169 |
|